These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 16696194)
21. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program. Griffiths T; Connors A Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174 [TBL] [Abstract][Full Text] [Related]
22. Rapid/automated ID methods survey. PDA Microbial ID Task Force. Parenteral Drug Association. J Parenter Sci Technol; 1990; 44(4):216-22. PubMed ID: 2213430 [No Abstract] [Full Text] [Related]
23. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related]
25. Natural product drug discovery: the times have never been better. Galm U; Shen B Chem Biol; 2007 Oct; 14(10):1098-104. PubMed ID: 17961822 [TBL] [Abstract][Full Text] [Related]
26. United States Parmacopeia Chapter <797> timeline: 1989 to 2013. Newton DW Int J Pharm Compd; 2013; 17(4):283-8. PubMed ID: 24261142 [TBL] [Abstract][Full Text] [Related]
27. Microbial diversity in pharmaceutical product recalls and environments. Jimenez L PDA J Pharm Sci Technol; 2007; 61(5):383-99. PubMed ID: 18047177 [TBL] [Abstract][Full Text] [Related]
28. An industry commentary on regulatory issues--microbiology. Moldenhauer JE PDA J Pharm Sci Technol; 2002; 56(2):60-4. PubMed ID: 11977405 [No Abstract] [Full Text] [Related]
29. Continuous Microbiological Environmental Monitoring for Process Understanding and Reduced Interventions in Aseptic Manufacturing. Weber J; Hauschild J; Ijzerman-Boon P; Forng RY; Horsch J; Yan L; Prasad A; Henry RB; Claassen M; Villari P; Shereefa S; Wyatt J; Bolden JS; Pycke JT; Dassu D PDA J Pharm Sci Technol; 2019; 73(2):121-134. PubMed ID: 30361285 [TBL] [Abstract][Full Text] [Related]
31. Validation study on how to avoid microbial contamination during pharmaceutical production. Shintani H Biocontrol Sci; 2015; 20(1):1-10. PubMed ID: 25817807 [TBL] [Abstract][Full Text] [Related]
32. Why and how to implement a rapid sterility test. Gressett G; Vanhaecke E; Moldenhauer J PDA J Pharm Sci Technol; 2008; 62(6):429-44. PubMed ID: 19634346 [TBL] [Abstract][Full Text] [Related]
33. Environmental and Personnel Monitoring Programs-A Risk-Based Case Study of Tidswel EC; Boone K PDA J Pharm Sci Technol; 2020; 74(4):408-422. PubMed ID: 32060223 [TBL] [Abstract][Full Text] [Related]
35. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1. Martin M Int J Pharm Compd; 2018; 22(5):401-404. PubMed ID: 30384338 [TBL] [Abstract][Full Text] [Related]
36. [Environmental Monitoring in a Pharmaceutical Manufacturing Facility Using a Culture Independent Approach]. Kawai M Yakugaku Zasshi; 2022; 142(1):33-37. PubMed ID: 34980749 [TBL] [Abstract][Full Text] [Related]
37. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]